|
|
|
SENSEX
|
|
-364.20
|
-1.52%
|
23587.50
|
|
|
NIFTY
|
|
-1176.46
|
-1.49%
|
78041.59
|
|
|
Nasdaq
|
|
199.83
|
1.03%
|
19572.60
|
|
|
Nikkei 225
|
|
-111.68
|
-0.29%
|
38701.90
|
|
|
FTSE 100
|
|
-20.70
|
-0.26%
|
8084.60
|
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
BSE Code |
543245
|
ISIN Demat |
INE068V01023
|
Book Value (Rs) |
556.82
|
|
NSE Code |
GLAND
|
Dividend Yield % |
1.13
|
Market Cap (Rs) |
291569.36
|
|
TTM PE(x) |
26.44
|
TTM EPS(Rs) |
66.94
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
Incorporation Year
|
20-03 1978
|
Registered Office
|
Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal- Malkajgiri District, Hyderabad, Telangana-500043 .
|
ISINNO
|
INE068V01023
|
Phone
|
040 30510999
|
E-mail
|
gland@glandpharma.com / investor@glandpharma.com |
URL
|
www.glandpharma.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Srinivas Sadu
|
Managing Director
|
|
Company Secretary
|
Sampath Kumar Pallerlamudi
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|